Emergent BioSolutions (EBS) Other Non-Current Assets (2010 - 2026)

Emergent BioSolutions' Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $13.0 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 251.35% year-over-year to $13.0 million; the TTM figure through Mar 2026 stood at $13.0 million (up 251.35% YoY), while the FY2025 annual figure was $14.2 million, down 24.87% from the prior year.
• Other Non-Current Assets was $13.0 million for Q1 2026 at Emergent BioSolutions, down from $14.2 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $57.1 million in Q1 2022 to a low of $500000.0 in Q1 2024.
• Historically, Other Non-Current Assets has averaged $17.9 million across 4 years, with a median of $9.8 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets sank 60.08% in 2022, then soared 640.0% in 2025.
• A 4-year view of Other Non-Current Assets shows it stood at $40.8 million in 2022, then sank by 53.68% to $18.9 million in 2024, then slipped by 24.87% to $14.2 million in 2025, then declined by 8.45% to $13.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $13.0 million (Q1 2026), $14.2 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.